Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details)

v3.20.1
Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Net revenue $ 21,867,169 $ 15,080,211
Direct operating costs 13,566,730 9,847,540
Selling and marketing 1,581,353 361,399
General and administrative 5,592,725 4,162,076
Research and development 2,333,126 254,656
Change in contingent consideration   (64,203)
Depreciation and amortization 1,332,786 756,740
Impairment charges 297,651
Total operating expenses 24,704,371 15,318,208
Operating income (loss) (2,837,202) (237,997)
Healthcare IT [Member]    
Net revenue 18,840,865 12,119,744
Direct operating costs 11,165,926 7,474,454
Selling and marketing 1,572,772 351,951
General and administrative 3,880,222 2,462,403
Research and development 2,333,126 254,656
Change in contingent consideration   (64,203)
Depreciation and amortization 1,253,289 677,987
Impairment charges 297,651  
Total operating expenses 20,502,986 11,157,248
Operating income (loss) (1,662,121) 962,496
Practice Management [Member]    
Net revenue 3,026,304 2,960,467
Direct operating costs 2,400,804 2,373,086
Selling and marketing 8,581 9,448
General and administrative 556,508 396,370
Research and development
Change in contingent consideration  
Depreciation and amortization 79,497 78,753
Impairment charges  
Total operating expenses 3,045,390 2,857,657
Operating income (loss) (19,086) 102,810
Unallocated Corporate Expenses [Member]    
Net revenue
Direct operating costs
Selling and marketing
General and administrative 1,155,995 1,303,303
Research and development
Change in contingent consideration  
Depreciation and amortization
Impairment charges  
Total operating expenses 1,155,995 1,303,303
Operating income (loss) $ (1,155,995) $ (1,303,303)